Dexamethasone to prednisolone rotation relieved hiccups in colorectal cancer patient continuing teleworking during anticancer therapy
- PMID: 37351354
- PMCID: PMC10282110
- DOI: 10.1002/ccr3.7367
Dexamethasone to prednisolone rotation relieved hiccups in colorectal cancer patient continuing teleworking during anticancer therapy
Abstract
We present a case of chemotherapy-induced hiccups that were alleviated by steroid rotation. Hiccups are often overlooked, but they have an impact on the patient's quality of life. In the COVID-19 era, web-based teleworking has become an important tool, hiccups during a teleconference should be noted as a concern for patients.
Keywords: colorectal cancer; dexamethasone; hiccups; prednisolone; steroid rotation; teleworking.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Conflict of interest statement
The Department of Hospital Pharmaceutics, School of Pharmacy, Showa University received funds from Ono for a contract research project according to a collaborative research agreement. YO's kin is employed from Mitsubishi Tanabe Pharma. KS is a medical adviser of Ono, Taiho, and Sawai. As a potential conflict of interest, Hospital Pharmaceutics received research grants from Daiichi Sankyo, Mochida, Shionogi, Ono, Taiho, Nippon‐kayaku, and Bayer. TN received an honorarium fee for presentations from Sanofi. KM received an honorarium fee for presentations from Nippon‐Kayaku and Abbvie Inc. YK received an honorarium fee for presentations from Daiichi Sankyo. HT received an honorarium fee for presentations from Daiichi Sankyo, Taiho, Bristol‐Myers. KS received an honorarium fee for presentations from Daiichi Sankyo, Ono, Taiho, Yakult, Bristol‐Myers. KT received an honorarium for presentations at AYUMI, Daiichi Sankyo, TERUMO, Chugai, Towa, and Taisho. The other authors declare no conflict of interest associated with this manuscript.
Figures
References
-
- Ergen M, Arikan F, Fırat Çetin R. Hiccups in cancer patients receiving chemotherapy: a cross‐sectional study. J Pain Symptom Manage. 2021;62:e85‐e90. - PubMed
-
- Yamada Y, Yamaguchi T, Matsumoto H, et al. Phase II study of oral S‐1 with irinotecan and bevacizumab (SIRB) as first‐line therapy for patients with metastatic colorectal cancer. Invest New Drugs. 2012;30:1690‐1696. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
